Neuroreceptor gene polymorphisms and olanzapine depressive symptom response in schizophrenia

J Clin Psychopharmacol. 2007 Oct;27(5):520-3. doi: 10.1097/JCP.0b013e31814f4d82.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / pharmacology*
  • Benzodiazepines / pharmacology*
  • Depressive Disorder / drug therapy
  • Depressive Disorder / etiology
  • Double-Blind Method
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Olanzapine
  • Oligonucleotide Array Sequence Analysis
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Psychometrics
  • Receptors, Adrenergic / genetics
  • Receptors, Dopamine / genetics
  • Receptors, Serotonin / genetics
  • Remission Induction
  • Schizophrenia / complications
  • Schizophrenia / drug therapy*
  • Schizophrenia / genetics

Substances

  • Antipsychotic Agents
  • Receptors, Adrenergic
  • Receptors, Dopamine
  • Receptors, Serotonin
  • Benzodiazepines
  • Olanzapine